CellChorus to present at the 2022 Texas Life Science Forum
PRESS RELEASE
HOUSTON, Texas — February 16, 2022 — CellChorus Inc., the leader in applying artificial intelligence to visually evaluate how thousands of individual cells perform over time, will present at the 2022 Texas Life Science Forum.
The Texas Life Science Forum is a premier life science event in Texas that features participation from representatives from established leaders in life sciences, emerging life science companies, top academic institutions, and investors. The 10th forum will be held in person at Rice University on February 24, 2022.
“We are excited to share our recent progress with the life sciences community in Texas and guests from outside the state,” said Daniel Meyer, CEO of CellChorus. “The Rice Alliance and BioHouston have done an excellent job attracting leaders and investors from the life sciences community such as Dr. Stephen Hahn, the former Commissioner of the U.S. Food and Drug Administration, who is also a Rice Alumnus and the former Chief Medical Executive at The University of Texas MD Anderson Cancer Center.”
Additional details can be found below:
Event: Texas Life Science Forum
Date: Thursday, February 24, 2022
Location: Jones Graduate School of Business, McNair Hall, Rice University
Registration: Available at this link (closes Friday, February 18 at 5:00 pm CDT)
An example of the CellChorus TIMING platform showing a single well out of 1000s on the CellChorus array, including a T cell with specificity for the Spike protein (position 424-433) of the novel coronavirus SARS-CoV-2 (COVID-19) from a recovered patient that exhibits serial killing of cells expressing the spike protein.
About CellChorus
CellChorus is the leader in applying artificial intelligence to visually evaluate how thousands of individual immune cells, such as T cells and NK cells, perform over time. The company applies Time lapse Imaging Microscopy in Nanowell Grids (TIMING™) with neural network-based artificial intelligence (AI) to identify cells and evaluate their activity, including how they move, activate, kill and survive. The patent-protected CellChorus platform can link TIMING data and insights with information from other analysis modalities such as single-cell RNA sequencing and flow cytometry to provide a comprehensive understanding of cellular function, state and phenotype for the life sciences industry. Please visit cellchorus.com for more information.
Company Contact:
Daniel Meyer
Chief Executive Officer
CellChorus Inc.
TIMING@cellchorus.com
SOURCE CellChorus Inc.